Microfluidic single-cell transcriptional analysis rationally identifies novel surface marker profiles to enhance cell-based therapies

Current progenitor cell therapies have only modest efficacy, which has limited their clinical adoption. This may be the result of a cellular heterogeneity that decreases the number of functional progenitors delivered to diseased tissue, and prevents correction of underlying pathologic cell populatio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Commun
Main Authors: Rennert, Robert C., Januszyk, Michael, Sorkin, Michael, Rodrigues, Melanie, Maan, Zeshaan N., Duscher, Dominik, Whittam, Alexander J., Kosaraju, Revanth, Chung, Michael T., Paik, Kevin, Li, Alexander Y., Findlay, Michael, Glotzbach, Jason P., Butte, Atul J., Gurtner, Geoffrey C.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512622/
https://ncbi.nlm.nih.gov/pubmed/27324848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms11945
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares